-
Bristol-Myers Squibb signs on as sponsor of TV host Robin Roberts’ new digital docuseries
fiercepharma
December 06, 2018
Bristol-Myers Squibb has teamed up with ABC's "Good Morning America" co-anchor Robin Roberts to spotlight ordinary yet extraordinary people who’ve risen above and beyond major challenges.
-
Rivaroxaban reduced blood clots and related death in cancer patients
europeanpharmaceuticalreview
December 05, 2018
Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths…
-
Global 2-year trial reports on CAR-T therapy to treat DLBCL
europeanpharmaceuticalreview
December 04, 2018
A study has reported results of a clinical trial using CAR-T therapy where over half of the cancer patients were alive two year after the start…
-
Teva Recalls Two Blood Pressure Medications
drugs
December 03, 2018
All lots of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide combination blood pressure tablets have been recalled by Teva ....
-
Nanoscale blood test could discover more from cancer patients’ blood
europeanpharmaceuticalreview
December 03, 2018
A nanoscale blood test could be used to gain more information from the blood of patients in order to help the identification of cancer in its early stages…
-
Firdapse (Amifampridine) Approved for Rare Autoimmune Disorder
drugs
November 30, 2018
Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults with Lambert-Eaton myasthenic syndrome (LEMS).....
-
Hikma rises on cancer generic deal with China’s Hansoh
pharmaphorum
November 30, 2018
UK-listed Hikma Pharma has licensed an array of injectable cancer drugs from China’s Hansoh, sparking a rise in its share price....
-
Oncolytics Biotech Appoints CMO
contractpharma
November 30, 2018
Oncolytics Biotech announced that Dr. Rita Laeufle, M.D., Ph.D., who has been working as a consultant for Oncolytics for the last four months, has been appointed as chief medical officer. Dr. Laeufle will oversee the clinical development plan for pelareo
-
RCGP calls for better access to cancer diagnostic tests
pharmatimes
November 29, 2018
GP access to appropriate diagnostic tests in the community is currently amongst the lowest in Europe, a report by The Health Foundation has found.
-
Nuformix expands licensing agreement with NSB for NXP001
pharmaceutical-technology
November 29, 2018
Nuformix has expanded its licensing agreement with its Chinese licensing partner Newsummit Biopharma (NSB) for NXP001, which is being developed for cancer supportive care.....